Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05815485
Status:
RECRUITING
Last Update Posted:
2023-10-31
First Post:
2023-04-13
Brief Title:
A Randomized Double-Blind Placebo-Controlled Phase 23 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 COVID-19 or Pneumonia
Sponsor:
Organization:
University of Michigan